Cryz S - Search Results

1

Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines.

Levine MM, Hone D, Tacket C, Ferreccio C, Cryz S. Levine MM, et al. Among authors: cryz s. Res Microbiol. 1990 Sep-Oct;141(7-8):807-16. doi: 10.1016/0923-2508(90)90114-6. Res Microbiol. 1990. PMID: 2101470 Free article. Review.

2

Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial.

Levine MM, Ferreccio C, Cryz S, Ortiz E. Levine MM, et al. Among authors: cryz s. Lancet. 1990 Oct 13;336(8720):891-4. doi: 10.1016/0140-6736(90)92266-k. Lancet. 1990. PMID: 1976928 Clinical Trial.

3

Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.

Tacket CO, Losonsky G, Taylor DN, Baron LS, Kopecko D, Cryz S, Levine MM. Tacket CO, et al. Among authors: cryz s. J Infect Dis. 1991 Apr;163(4):901-4. doi: 10.1093/infdis/163.4.901. J Infect Dis. 1991. PMID: 2010645

4

Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.

Levine MM, Kaper JB, Herrington D, Ketley J, Losonsky G, Tacket CO, Tall B, Cryz S. Levine MM, et al. Among authors: cryz s. Lancet. 1988 Aug 27;2(8609):467-70. doi: 10.1016/s0140-6736(88)90120-1. Lancet. 1988. PMID: 2900401 Clinical Trial.

5

Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.

Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, Cryz S. Levine MM, et al. Among authors: cryz s. Vaccine. 1999 Oct 1;17 Suppl 2:S22-7. doi: 10.1016/s0264-410x(99)00231-5. Vaccine. 1999. PMID: 10506405 Clinical Trial.

6

Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.

Herrington DA, Van de Verg L, Formal SB, Hale TL, Tall BD, Cryz SJ, Tramont EC, Levine MM. Herrington DA, et al. Among authors: cryz sj. Vaccine. 1990 Aug;8(4):353-7. doi: 10.1016/0264-410x(90)90094-3. Vaccine. 1990. PMID: 2204243 Clinical Trial.

7

Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR.

Tacket CO, Losonsky G, Nataro JP, Cryz SJ, Edelman R, Kaper JB, Levine MM. Tacket CO, et al. Among authors: cryz sj. J Infect Dis. 1992 Oct;166(4):837-41. doi: 10.1093/infdis/166.4.837. J Infect Dis. 1992. PMID: 1527420 Clinical Trial.

8

[Effectiveness of oral, attenuated live Salmonella typhi Ty 21a vaccine in controlled field trials].

Cryz SJ Jr, Fürer E, Levine MM. Cryz SJ Jr, et al. Schweiz Med Wochenschr. 1988 Apr 2;118(13):467-70. Schweiz Med Wochenschr. 1988. PMID: 3375787 Clinical Trial. German.

9

Vibrio cholerae CVD103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effects.

Cryz SJ Jr, Kaper J, Tacket C, Nataro J, Levine MM. Cryz SJ Jr, et al. Dev Biol Stand. 1995;84:237-44. Dev Biol Stand. 1995. PMID: 7796960 Review.

10

Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.

Cryz SJ Jr, Que JU, Levine MM, Wiedermann G, Kollaritsch H. Cryz SJ Jr, et al. Infect Immun. 1995 Apr;63(4):1336-9. doi: 10.1128/iai.63.4.1336-1339.1995. Infect Immun. 1995. PMID: 7890391 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters